Applications Of Biotechnology

In the context of biology, downstream processing refers to the stages following the production stage in biotechnological applications. This typically involves a series of steps required to purify bioproducts, especially if microorganisms or other biological entities are involved in the initial production. Below is a clarification of the options given:

1. Identification: The process of identifying biological entities or their components. While crucial, it is not considered part of downstream processing.
2. Amplification: Generally associated with increasing the number of copies of a specific DNA sequence. Similar to identification, it is not part of downstream processing.
3. Fermentation: A bioproduction process usually preceding downstream processing. It involves the cultivation of microorganisms to produce desired products.
4. Purification: This is the correct answer. In downstream processing, purification involves isolating and purifying the product from a mixture, removing impurities and other undesired components.

Therefore, the correct answer is Purification, as it is a critical step in downstream processing that ensures the final product is in a usable and safe form.

In the context of controlling bollworm pests, genetically engineered plants incorporate specific genes to produce toxins that target these pests. The CryIAc and CryIIAb genes are part of the Cry (crystal) protein family originating from Bacillus thuringiensis (Bt), a bacterium known for naturally producing insecticidal proteins.

These Cry genes are introduced into crop plants, enabling them to produce these proteins in their tissues, which are toxic to specific insects like bollworms but generally harmless to humans and other non-target organisms. When bollworms consume parts of the Bt plant, the Cry proteins bind to receptors in the gut of the insects, which leads to cell lysis and eventually the death of the insect, thus effectively controlling their population.

Other options such as RNAi (RNA interference) and dsRNA (double-stranded RNA) represent different gene-silencing technologies and mechanisms and are not directly used for controlling bollworms in this context. Therefore, the use of the CryIAc and CryIIAb genes in genetically modified crops is the correct answer for controlling the growth of bollworms.

The Polymerase Chain Reaction (PCR) is a widely used technique in molecular biology for amplifying DNA. It consists of three main steps:

• Denaturation: This step involves heating the double-stranded DNA to around 94-98°C to break the hydrogen bonds between the strands, resulting in two single-stranded DNA molecules.
• Annealing: The temperature is lowered to 50-65°C to enable the primers to bind (anneal) to their complementary sequences on the single-stranded DNA.
• Extension: During this step, the temperature is set to around 72°C. Taq polymerase, the enzyme used in PCR, synthesizes a new DNA strand by extending the primers using the original single strand as a template.

The correct identification of these steps is crucial for understanding the process of PCR. In the options given, Downstream processing is the correct answer as it is not a step in Polymerase Chain Reaction but rather a part of bioprocessing that involves the purification and recovery of products derived from biotechnological processes. Thus, it falls outside the scope of PCR steps.

DNA fingerprinting is a technique used to identify and compare DNA samples. The process involves several critical steps that must be performed in a specific sequence to ensure accuracy and reliability. Here is the correct sequence of steps involved in DNA fingerprinting:

1. Isolation of DNA (E): The process begins with the extraction of DNA from cells. This is crucial as it provides the template necessary for further analysis.
2. Digestion of DNA by restriction endonucleases (C): This step involves cutting the DNA into smaller fragments using specific enzymes known as restriction endonucleases.
3. Separation of DNA fragments by electrophoresis (B): The DNA fragments are then separated according to size using a technique called gel electrophoresis, which applies an electric field to move the fragments through a gel matrix.
4. Blotting of separated DNA fragments to nylon (D): Once separated, the DNA fragments are transferred from the gel onto a nylon membrane. This process is known as blotting and allows for further analysis.
5. Hybridization using labeled VNTR probe (A): Finally, specific DNA sequences are identified using labeled probes that bind to the variable number of tandem repeats (VNTRs), unique to every individual. This step facilitates the comparison and identification of DNA footprints.

Therefore, the correct sequence of steps is: (E), (C), (B), (D), (A).

In the field of biology, the term "Transforming Principle" was introduced by Frederick Griffith, a bacteriologist whose experiments conducted in 1928 led to this discovery. He performed a series of experiments using two strains of Streptococcus pneumoniae bacteria. The key steps of his experiment included:

• Smooth Strain (S): This strain had a polysaccharide capsule, making it virulent and able to cause disease.
• Rough Strain (R): This strain lacked a capsule and was non-virulent.
• Experimentation: Griffith found that when he injected mice with a mixture of heat-killed virulent S strain and live non-virulent R strain, the mice died. Moreover, live S strain bacteria could be isolated from the dead mice.

Griffith concluded that some "transforming principle" from the heat-killed S strain bacteria transformed the R strain into a virulent form. This groundbreaking concept later proved to be pivotal in identifying DNA as the genetic material.

The question asks which of the following is not a process of DNA recombinant technology:

1. Isolation of DNA
2. RNA interference (RNAi)
3. Introduction of Restriction endonucleases
4. Culturing the host cells in a medium at a large scale

To determine the correct answer, we need to understand the typical processes involved in recombinant DNA technology.

Recombinant DNA Technology Steps:

• Isolation of DNA: This is a crucial step in recombinant DNA technology where the DNA is extracted from cells to work with it.
• Introduction of Restriction Endonucleases: These enzymes are used to cut DNA at specific sequences, an essential step in creating recombinant DNA.
• Culturing the Host Cells in a Medium at Large Scale: After inserting the recombinant DNA into host cells, these cells need to be grown on a large scale to produce the desired product.

All the steps mentioned above are part of DNA recombinant technology processes.

RNA Interference (RNAi):

RNA interference is a biological process where RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. It is not part of creating recombinant DNA, instead, it's a method used to study gene function or regulate expressions post-transcriptionally.

Conclusion: The process that is not involved in DNA recombinant technology from the given options is RNA interference (RNAi).

(A) "Milk obtained from ‘Rosie’ is nutritionally more balanced for human babies than natural human milk." This statement is incorrect because while milk from ‘Rosie’, a transgenic cow, is genetically modified to be similar to human milk and may offer some nutritional benefits, claiming it is more balanced than natural human milk for babies is not universally validated.
(B) "Biopiracy refers to the use of bioresources without proper authorization from MNCs." This statement is misleading. Biopiracy involves exploiting bioresources without proper authorization or compensation to the indigenous people and nations owning those resources, not specifically related to MNCs.
(C) "GEAC is the decisive body for safety and validity of GMOs and GM research respectively." This statement is correct. The Genetic Engineering Appraisal Committee (GEAC) in India evaluates the safety and validity of genetically modified organisms and related research.
(D) "Transgenic animals help us to understand the contribution of genes in the development of disease." This statement is correct. Transgenic animals are engineered to study diseases, allowing scientists to understand genetic contributions to disease development and progression.

Therefore, the correct answer is (C) and (D) only.

The task is to match products listed in List-I with the corresponding organisms in List-II.

Explanation for the correct matches:

• Statin: Statins are a category of drugs that lower cholesterol levels, primarily produced by the fungus Monascus.
• Clot buster: Streptokinase, known as a clot buster, is an enzyme that can break down blood clots and is derived from the bacterium Streptococcus.
• Swiss cheese: Known for its characteristic holes and flavor, it is produced using the bacterium Propionibacterium which contributes to these features.
• Cyclosporin-A: This is an immunosuppressant drug, commonly sourced from the fungus Trichoderma.

The correct matches according to the given lists are: (A) - (III), (B) - (I), (C) - (IV), (D) - (II).